Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum
Original ArticlesMineral Metabolism/Bone Disease
You have accessRestricted Access

Sodium Thiosulfate Pharmacokinetics in Hemodialysis Patients and Healthy Volunteers

Stefan Farese, Emilie Stauffer, Robert Kalicki, Tatjana Hildebrandt, Brigitte M. Frey, Felix J. Frey, Dominik E. Uehlinger and Andreas Pasch
CJASN June 2011, 6 (6) 1447-1455; DOI: https://doi.org/10.2215/CJN.10241110
Stefan Farese
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emilie Stauffer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Kalicki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tatjana Hildebrandt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brigitte M. Frey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Felix J. Frey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominik E. Uehlinger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Pasch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Abstract

Background and objectives Vascular calcification is a major cause of morbidity and mortality in dialysis patients. Human and animal studies indicate that sodium thiosulfate (STS) may prevent the progression of vascular calcifications. The pharmacokinetics of STS in hemodialysis patients has not been investigated yet.

Design, setting, participants, & measurements STS was given intravenously to 10 hemodialysis patients on- and off-hemodialysis. Additionally, STS was applied to 9 healthy volunteers once intravenously and once orally. Thiosulfate concentrations were measured by using a specific and sensitive HPLC method.

Results In volunteers and patients, mean endogenous thiosulfate baseline concentrations were 5.5 ± 1.82 versus 7.1 ± 2.7 μmol/L. Renal clearance was high in volunteers (1.86 ± 0.45 ml/min per kg) and reflected GFR. Nonrenal clearance was slightly, but not significantly, higher in volunteers (2.25 ± 0.32 ml/min per kg) than in anuric patients (2.04 ± 0.72 ml/min per kg). Hemodialysis clearance of STS was 2.62 ± 1.01 ml/min per kg. On the basis of the nonrenal clearance and the thiosulfate steady-state serum concentrations, a mean endogenous thiosulfate generation rate of 14.6 nmol/min per kg was calculated in patients. After oral application, only 4% of STS was recovered in urine of volunteers, reflecting a low bioavailability of 7.6% (0.8% to 26%).

Conclusions Given the low and variable bioavailability of oral STS, only intravenous STS should be prescribed today. The biologic relevance of the high hemodialysis clearance for the optimal time point of STS dosing awaits clarification of the mechanisms of action of STS.

  • Received November 20, 2010.
  • Accepted February 6, 2011.
  • Copyright © 2011 by the American Society of Nephrology
View Full Text
PreviousNext
Back to top

In this issue

Clinical Journal of the American Society of Nephrology: 6 (6)
Clinical Journal of the American Society of Nephrology
Vol. 6, Issue 6
1 Jun 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in CJASN.
Enter multiple addresses on separate lines or separate them with commas.
Sodium Thiosulfate Pharmacokinetics in Hemodialysis Patients and Healthy Volunteers
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Sodium Thiosulfate Pharmacokinetics in Hemodialysis Patients and Healthy Volunteers
Stefan Farese, Emilie Stauffer, Robert Kalicki, Tatjana Hildebrandt, Brigitte M. Frey, Felix J. Frey, Dominik E. Uehlinger, Andreas Pasch
CJASN Jun 2011, 6 (6) 1447-1455; DOI: 10.2215/CJN.10241110

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Sodium Thiosulfate Pharmacokinetics in Hemodialysis Patients and Healthy Volunteers
Stefan Farese, Emilie Stauffer, Robert Kalicki, Tatjana Hildebrandt, Brigitte M. Frey, Felix J. Frey, Dominik E. Uehlinger, Andreas Pasch
CJASN Jun 2011, 6 (6) 1447-1455; DOI: 10.2215/CJN.10241110
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

Original Articles

  • Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse
  • Associations between Deprivation, Geographic Location, and Access to Pediatric Kidney Care in the United Kingdom
  • Variability in Culture-Negative Peritonitis Rates in Pediatric Peritoneal Dialysis Programs in the United States
Show more Original Articles

Mineral Metabolism/Bone Disease

  • Spine Trabecular Bone Score as an Indicator of Bone Microarchitecture at the Peripheral Skeleton in Kidney Transplant Recipients
  • Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial
  • Trabecular Bone Score and Incident Fragility Fracture Risk in Adults with Reduced Kidney Function
Show more Mineral Metabolism/Bone Disease

Cited By...

  • Urinary Sulfur Metabolites Associate with a Favorable Cardiovascular Risk Profile and Survival Benefit in Renal Transplant Recipients
  • Painful Skin Ulcers in a Hemodialysis Patient
  • Sodium Thiosulfate Therapy for Calcific Uremic Arteriolopathy
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire